Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Trust & governance

Conflicts of Interest

How relationships are disclosed and managed.

This page states how publisher, author, reviewer, provider, pharmacy, affiliate, and financial relationships are handled. Any material relationship triggers disclosure and editorial recusal, and never earns a provider favorable treatment or an easier evidence standard.

Covered relationships

Ownership, employment, affiliate or referral compensation, advertising, shared staff or contractors, sponsored content, and data relationships across the publisher, authors, reviewers, providers, and pharmacies.

Current disclosed relationships

As of September 4, 2026: NexLife — commercial partnership (affiliate/referral), disclosed on the ownership & funding page and at every point of use; NexLife links carry rel="sponsored". No other covered provider or pharmacy relationship is on record.

Recusal

A person with a material relationship to a covered entity recuses from writing, reviewing, or ranking that entity. Rankings are generated from data, not prose, so no individual can hand-place a provider.

Frequently asked questions

Does a relationship change a provider's ranking?

No. Rankings come from data and identical evidence rules. A relationship is disclosed and the related staff recuse; it never yields a better score.

Publisher: Microdose GLP One. Compounded medications are not FDA approved. Questions or corrections: see the corrections policy and contact page.